The Translational Platform for Virus, Vaccine and Cancer Research (TPVC) is an integral part of the Laboratory of Virology and Antiviral Research at the Rega Institute, led by Prof. Johan Neyts. TPVC bridges fundamental research and clinical translation by developing and implementing innovative technologies, models, and translational research programs. Together, the laboratory and TPVC are dedicated to advancing innovative antiviral strategies against viruses that pose a significant public health threat.

Project

Enteroviruses and rhinoviruses cause a broad range of diseases, from severe neurological disorders to asthma/COPD exacerbations. Despite this global health burden, no approved antiviral treatments are currently available. This PhD aims to accelerate antiviral target discovery by combining state-of-the-art high-content imaging and phenotypic Cell Painting profiling with AI-driven data analysis. The project will leverage innovative experimental an...